The 20 Best Oral Squamous Cell Carcinoma Doctors Near Me in Vienna, 9

Wojtek Mydlarz, director of Johns Hopkins Head and Neck Surgery in the National Capital Region, specializes in the treatment of benign and malignant tumors of the head and neck, including the upper aerodigestive tract, salivary glands, skull base, thyroid, skin and soft tissue. Dr. Mydlarz is a medical officer and a clinical and research collaborator in the head and neck surgery branch of the National Institutes of Health (NIH). His research interests include evaluating both surgical and nonsurgical treatment outcomes in patients with head and neck cancer. He is interested in the complex molecular biology of head and neck cancer, as well as potential clinical applications of novel targeted cancer therapies. He is actively involved in clinical trial development and implementation at the NIH and Johns Hopkins. After earning his medical degree from the Johns Hopkins University School of Medicine, Dr. Mydlarz completed his internship and residency in otolaryngology–head and neck surgery at The Johns Hopkins Hospital. Additionally, he completed a Science of Clinical Investigation Training Program at Johns Hopkins Bloomberg School of Public Health and specialized fellowship training in head and neck surgical oncology at the University of Texas MD Anderson Cancer Center. Dr. Mydlarz has contributed to numerous professional publications, authored a variety of articles and book chapters, and has been invited to give many lectures. He serves on the editorial board for Oral Oncology and Laryngoscope Investigative Otolaryngology, and is a journal reviewer for Oral Oncology, Head and Neck, Laryngoscope and JAMA Otolaryngology–Head and Neck Surgery. Dr. Mydlarz is rated as an Advanced provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. He is also highly rated in 4 other conditions, according to our data. His clinical expertise encompasses Head and Neck Squamous Cell Carcinoma (HNSCC), Tongue Cancer, Salivary Gland Tumors, Laryngectomy, and Tissue Biopsy. Dr. Mydlarz is board certified in Head And Neck Surgery.

Patty Lee is an Otolaryngologist practicing medicine in Fairfax, Virginia. Dr. Lee is rated as a Distinguished provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. She is also highly rated in 33 other conditions, according to our data. Her clinical expertise encompasses Tongue Cancer, Adenoid Cystic Carcinoma, Acinic Cell Carcinoma of Salivary Glands, Gastrostomy, and Thyroidectomy.

Shaun Desai is an Otolaryngologist and a Plastic Surgeon practicing medicine in Bethesda, Maryland. He has been practicing medicine for over 17 years. Dr. Desai is rated as an Experienced provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. His clinical expertise encompasses Facial Paralysis, Aseptic and Alopecic Nodules of Scalp (AANS), Melanoma, Osteotomy, and Bone Graft. Dr. Desai is board certified in American Board Of Facial Plastic And Reconstructive Surgery and Head And Neck Surgery.

Nyall London has a unique clinical practice focused on the care of patients with sinonasal and skull base cancers. As one of the few surgeons trained in both head and neck cancer surgery, as well as rhinology and skull base surgery, he offers patients comprehensive sinonasal tumor surgical care, including open and endoscopic approaches as well as neck dissection surgery. Dr. London has developed notable patient education events about the multidisciplinary and long-term care of patients with sinonasal malignancies. Additionally, he is an innovator of clinical trials for these rare tumors, with open clinical trial options available and multiple others in development. Internationally recognized for his expertise in the care of patients with sinonasal and skull base cancers, Dr. London was an associate editor for the first international consensus statement on sinonasal tumors, and was appointed president of the International Network for Sinonasal Cancer Research (2024–26). He directs a research laboratory at the National Cancer Institute/National Institutes of Health focused on therapeutic advances and mechanisms of sinonasal tumorigenesis. Dr. London has published more than 130 peer-reviewed research articles, reviews and book chapters, including co-first author publications in Nature, Nature Medicine, Science Translational Medicine and Nature Cell Biology. He earned his medical and doctoral degrees from the University of Utah, and completed his residency in otolaryngology–head and neck surgery at Johns Hopkins. He also accomplished a fellowship in open and endoscopic head and neck and skull base surgery at The Ohio State University, under the direction of Dr. Ricardo Carrau. Dr. London is rated as an Experienced provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. He is also highly rated in 14 other conditions, according to our data. His clinical expertise encompasses Olfactory Neuroblastoma, Sinus Cancer, Teratocarcinosarcoma, Endoscopy, and Craniectomy. Dr. London is board certified in Head And Neck Surgery.

Brandi Page, M.D., is an assistant professor of radiation oncology and molecular sciences for Johns Hopkins Radiation Oncology Department at Suburban Hospital and a radiation oncologist at the Johns Hopkins Kimmel Cancer Center at Sibley Memorial Hospital. Dr. Page has expertise in treating all types of cancer and, for the last several years, has become a highly sought-after specialist in the National Capitol Region (NCR-MD/DC/VA) for her expertise in treating head and neck and brain/central nervous system tumors. In Dr. Page's role with Johns Hopkins she has brought new complex radiotherapy services to the facility and facilitated the team building environment for collaborating practitioners and caregivers in the region. Dr. Page also serves on the Cancer Committee for Sibley and Suburban Hospitals for the American Cancer Society, which brings together multidisciplinary care providers to collaborate on initiatives for continued excellence. She is a teaching faculty member at the Johns Hopkins School of Medicine for medical students, residents and fellows, is the current director of radiation oncology fellowships, initiating and growing the first radiation oncology fellowship at the institution a year after the initiation of the proton center. Dr. Page earned her medical degree at Albany Medical College, completed residency in radiation oncology at the Huntsman Cancer Institute at the University of Utah, and fellowship in translational radiation oncology at Wake Forest University Medical Center, where she earned the Service Excellence in Patient Care Award. At Johns Hopkins she has won awards for clinical excellence nominated by peers many years in a row and a Faculty of the Year award for her teaching efforts. Dr. Page is a member of the American Society of Therapeutic Radiation Oncology, a diplomate of the American Board of Radiology, and a Fellow of the American College of Radiation Oncology. Dr. Page has served on the Board of Directors for Radiating Hope and currently serves on the Board of Directors for Courage Unmasked/911-4-HNC (a Head and Neck Cancer support organization). Dr. Page frequently serves as a sought after reviewer for peer reviewed articles and has served as the Continuing Medical Education Editor for the International Journal of Radiation Oncology Biology Physics (IJROBP). Dr. Page believes the best way to empower patients is with knowledge and partnership and she looks forward to partnering with patients in treating their condition, and helping them successfully get through their treatment and maximize opportunities for a happy healthy life after treatment. Make A Gift LinkedIn https://www.linkedin.com/in/brandi-page-968650b0. Dr. Page is rated as an Experienced provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Brain Tumor, Throat Cancer, Laryngeal Cancer, Glioma, and Gamma Knife Radiosurgery. Dr. Page is board certified in American Board Of Radiology.

Snehal Patel is an Oral and Maxillofacial Surgeon practicing medicine in Vienna, Virginia. Dr. Patel is rated as an Experienced provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. His clinical expertise encompasses Oral Squamous Cell Carcinoma. Dr. Patel is currently accepting new patients.

Nancy Judd is an Otolaryngologist practicing medicine in Mclean, Virginia. Dr. Judd is rated as an Experienced provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. Her clinical expertise encompasses Tongue Cancer, Male Pattern Baldness, Oral Squamous Cell Carcinoma, Parathyroidectomy, and Tissue Biopsy.

Marietta Tan is an Otolaryngologist practicing medicine in Mclean, Virginia. She has been practicing medicine for over 17 years. Dr. Tan is rated as an Experienced provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. She is also highly rated in 8 other conditions, according to our data. Her clinical expertise encompasses Adenoid Cystic Carcinoma, Salivary Gland Tumors, Male Pattern Baldness, Laryngectomy, and Gastrostomy.

Arjun Joshi is a Plastic Surgeon and a Surgical Oncologist practicing medicine in Reston, Virginia. Dr. Joshi is rated as an Experienced provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Salivary Duct Stones, Sialadenitis, Laryngeal Cancer, Laryngectomy, and Glossectomy.

Dr. Deeken joined Inova in 2013 and has more than 21 years of clinical experience in internal medicine and medical oncology. He serves as the President of Inova Schar Cancer Institute and Medical Director for the Inova Schar Head and Neck Cancer Program. His clinical research focuses on the use of immunotherapy treatments while his laboratory research takes a closer look at understanding the growing epidemic of head and neck cancers caused by HPV. This includes understanding the tumor mutations that are induced by HPV infection and how those tumors can be better treated with targeted therapies. He believes that gaining a better understanding of genomic factors may explain who might be at risk for developing HPV-caused head and neck cancer. Dr. Deeken served on the national Head and Neck Cancer Scientific Committee for the American Society of Clinical Oncology (ASCO) and currently serves on ASCO's Government Relations Committee. Prior to joining Inova, he was Director of the Head and Neck Medical Oncology Program at the Lombardi Comprehensive Cancer Center at Georgetown University and Regional Director for Medical Oncology for MedStar Health. He currently serves as Professor of Medicine at the University of Virginia. Dr. Deeken received his Doctor of Medicine from Georgetown University, where he also did his residency in internal Medicine. He did his fellowship training in medical oncology at the National Cancer Institute. A native of Wisconsin, Dr. Deeken is married and has 4 children. Dr. Deeken is rated as an Advanced provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. He is also highly rated in 6 other conditions, according to our data. His clinical expertise encompasses Laryngeal Cancer, Head and Neck Squamous Cell Carcinoma (HNSCC), Throat Cancer, and Oral Squamous Cell Carcinoma.

Nicholas Farrell is a Hematologist Oncology provider practicing medicine in Bethesda, Maryland. Dr. Farrell is rated as an Experienced provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. He is also highly rated in 47 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Childhood Iron Deficiency Anemia, Pleuropulmonary Blastoma, and Iron Deficiency Anemia. Dr. Farrell is board certified in American Board Of Internal Medicine.

Mark Domanski is an Otolaryngologist and a Plastic Surgeon practicing medicine in Fairfax, Virginia. Dr. Domanski is rated as an Experienced provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. His clinical expertise encompasses Tongue Cancer, Breast Enlargement In Males, Oral Squamous Cell Carcinoma, Melanoma, and Tissue Biopsy.

Dr. Gopal Bajaj is the President of Radiation Oncology Associates, PC, and the emeritus Chairman and Medical Director of the Department for Advanced Radiation Oncology and Proton Therapy for Inova Schar Cancer Institute, having served in this role from 2014 to 2020. Prior to joining the radiation oncology practice at Inova Fairfax Hospital, he was an instructor in radiation oncology, medical oncology, and otolaryngology head and neck surgery at Johns Hopkins Hospital. His clinical focus and academic interests center on providing high level, multidisciplinary treatment to patients with head and neck malignancies, educating the next generation of medical specialists, exploring novel mechanisms of radiation-associated toxicity management, and working with emerging technologies in radiation oncology. His additional area of interest includes radiation therapy for benign disease, with a specific focus on Dupuytren’s and Ledderhose diseases. Dr. Bajaj oversees one of the nation’s busiest practices for the treatment of Dupuytren’s and Ledderhose diseases with radiotherapy and is actively involved in research, physician training and patient advocacy for these conditions. He presently serves as an Associate Professor of Radiation Oncology for the University of Maryland School of Medicine, Virginia Commonwealth University School of Medicine and the Uniformed Services University of the Health Sciences. Dr. Bajaj was raised in Overland Park, KS, and graduated with honors from the University of Kansas, receiving dual degrees in biology and genetics. He received his medical degree from the University of Kansas School of Medicine, where he was elected to the Alpha Omega Alpha Medical Honor Society. He has also performed cancer research at the Otto-von-Guericke Universität in Magdeburg, Germany, and gastrointestinal oncology training at the University of Amsterdam’s Academish Medisch Centrum. He went on to complete an internal medicine internship at Harvard. Dr. Bajaj is rated as an Experienced provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. He is also highly rated in 39 other conditions, according to our data. His clinical expertise encompasses Adenoid Cystic Carcinoma, Pleuropulmonary Blastoma, Breast Cancer, and Metastatic Brain Tumor.

Dr. Lonika Majithia is currently the Medical Director of Brachytherapy and Director of Educational Programs at Radiation Oncology Associates, and is board certified in radiation oncology. She joined Radiation Oncology Associates in 2016. Her clinical interests include gynecologic, breast, CNS, GI, thoracic and hematologic malignancies. Dr. Majithia is experienced with multiple radiotherapy techniques including volumetric modulated arc therapies (VMAT), intensity modulated radiation therapy (IMRT), stereotactic body radiotherapy, Gamma Knife and CyberKnife Radiosurgery, intra-operative radiotherapy (IORT), eye plaque brachytherapy, and prostate and gynecologic brachytherapy, including High Dose Rate (HDR) brachytherapy. Dr. Majithia grew up in Albuquerque, NM. She graduated magna cum laude from the University of New Mexico with dual bachelor’s degrees in biology and physics. She was awarded the UNM Merit Scholarship and actively participated in physics and basic science research. She completed her medical training at the University of New Mexico where she was elected to the Alpha Omega Alpha Medical Honor Society. She completed her preliminary medicine internship at the Medical College of Wisconsin in Milwaukee, WI and her radiation oncology residency at The Ohio State University in Columbus, OH. She served as Chief Resident during her last year of residency and remained active in academic pursuits including research and medical education. During her residency, she presented multiple abstracts and presentations at the American Society for Radiation Oncology (ASTRO) annual meetings and American Society of Clinical Oncology (ASCO) meetings. She has published book chapters, written retrospective review articles, and assisted in the development of a phase I clinical trial in hematologic malignancies. During her residency, she also completed a master’s degree in medical sciences. Dr. Majithia is rated as an Experienced provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. She is also highly rated in 37 other conditions, according to our data. Her clinical expertise encompasses Breast Cancer, Metastatic Brain Tumor, Neuroendocrine Carcinoma of the Cervix, and Cervical Cancer.

Mustafa Abugideiri is a Radiation Oncologist practicing medicine in Fairfax, Virginia. Dr. Abugideiri is rated as an Experienced provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. He is also highly rated in 28 other conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Pleuropulmonary Blastoma, and Breast Cancer.

Dr. Michael J. Eblan is a specialty care physician board certified in radiation oncology at Radiation Oncology Associates, which he joined in 2016. Prior to joining Radiation Oncology Associates, he completed his internal medicine internship and radiation oncology residency at the University of North Carolina at Chapel Hill. There, he served as chief resident, led quality and safety initiatives to improve patient care, and designed prospective clinical investigations of circulating tumor cells as a novel biomarker for radiation treatment response. During his residency, Dr. Eblan also completed additional training in CyberKnife robotic radiosurgery and earned a Lean Six Sigma Yellow Belt certification. Much of his research has focused on the effects of radiation on normal tissues and the development of nanotherapeutics to improve the efficacy of chemoradiotherapy and immunotherapy at the Carolina Center of Cancer Nanotechnology Excellence. Dr. Eblan is trained in all aspects of radiation oncology and has particular clinical interest in thoracic, gastrointestinal, breast, prostate, brain, head and neck, hematologic, and pediatric malignancies. He is experienced with multiple radiotherapy techniques, including proton beam therapy, volumetric modulated arc therapies, intensity-modulated radiation therapy, stereotactic body radiotherapy, CyberKnife radiosurgery, intraoperative radiotherapy, and prostate and gynecologic brachytherapy, including high-dose-rate brachytherapy. His work has been recognized by the American Society for Radiation Oncology, the American Association for Cancer Research, the Conquer Cancer Foundation and the American Society of Clinical Oncology. Dr. Eblan grew up in Fairfax County and graduated with distinction as an Echols Scholar from the University of Virginia, receiving dual degrees in biology and economics. He then trained at the National Institutes of Health in Bethesda, MD, through a postbaccalaureate Intramural Research Training Award and published numerous research articles on genetic alterations contributing to human disease, including publication in the New England Journal of Medicine. He received his medical degree from the University of Pennsylvania School of Medicine, where he was awarded the Ruth L. Kirschstein National Research Service Award to study cancer biology and proton radiotherapy. Dr. Eblan is rated as an Experienced provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. He is also highly rated in 35 other conditions, according to our data. His clinical expertise encompasses Primitive Neuroectodermal Tumor (PNET), Posterior Fossa Tumor, Prostate Cancer, and Familial Prostate Cancer.

Janakiraman Subramanian is an Oncologist practicing medicine in Fairfax, Virginia. Dr. Subramanian is rated as an Experienced provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. He is also highly rated in 12 other conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, Bone Marrow Aspiration, and Tissue Biopsy.

Dr. Tobias Chapman is a specialty care physician board certified in radiation oncology. He joined Inova Schar Cancer Institute in 2019 with more than eight years of clinical experience. Prior to joining Inova Schar, he served as faculty at Harvard. Dr. Chapman is rated as an Experienced provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. He is also highly rated in 23 other conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, HER-2 Positive Breast Cancer, and Metastatic Brain Tumor.

Mather Chair, Radiation Oncology Department Chair and System Division Chief, Inova Radiation Oncology Inova Schar CancerDr. Ashish Chawla is a specialty care physician board certified in radiation oncology at Radiation Oncology Associates, which he joined in 2011.He received his undergraduate degree from Pennsylvania State University, graduating with honors in biology. He received his medical degree from Thomas Jefferson University in Philadelphia in 1998, where he was elected to the prestigious Alpha Omega Alpha Medical Honor Society. He completed his radiation oncology training at Harvard’s Massachusetts General Hospital in 2003. There, he won awards for scholarly research as a radiation oncology resident. He has published several peer-reviewed articles related to breast, prostate and gastrointestinal cancer management.Prior to joining Radiation Oncology Associates, he served as a radiation oncologist at Anne Arundel Medical Center in Annapolis, MD. There, he helped lead innovative clinical research as the principal investigator for breast cancer protocols with the Radiation Therapy Oncology Group. He also helped lead the cancer center’s stereotactic radiosurgery program and served as cancer liaison for the American College of Surgeons’ Commission on Cancer. He led numerous studies involving partial breast irradiation as well as prostate, central nervous system, and head and neck cancer investigations.Dr. Chawla’s clinical interests include the multidisciplinary management of breast cancer and prostate cancer patients, and he is the Director of the Partial Breast Irradiation Program at Inova Fairfax Hospital. He has expertise in the use of stereotactic radiosurgery and stereotactic body radiotherapy for tumors of the brain, spine and lung. Additional areas of clinical interest include gastrointestinal, lung, head and neck, and brain tumors.Dr. Chawla has been listed in Washingtonian magazine, Northern Virginia Magazine, and U.S. News and World Report as “Top Doctor” for radiation oncology in the Washington, DC, and Northern Virginia areas. Dr. Chawla is rated as an Experienced provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. He is also highly rated in 27 other conditions, according to our data. His clinical expertise encompasses Breast Cancer, Familial Prostate Cancer, Prostate Cancer, and Pleuropulmonary Blastoma.

Dr. Kevin Choe is a specialty care physician board certified in radiation oncology at Inova Health System. He joined Inova in 2015 and has been practicing since 2005. Prior to joining Inova, Dr. Choe was on the faculty at University of Texas, Southwestern Medical Center in Dallas, TX, where he specialized in high-precision stereotactic radiotherapy. His research focused on elucidating the genetic alterations that contribute to cancer development and progression. He also designed and conducted clinical trials, investigating novel strategies to overcome treatment resistance in aggressive and metastatic cancers. Dr. Choe grew up in Fairfax, VA, and appreciates the opportunity to serve the community he cares deeply for. Dr. Choe is rated as an Experienced provider by MediFind in the treatment of Oral Squamous Cell Carcinoma. He is also highly rated in 34 other conditions, according to our data. His clinical expertise encompasses Familial Prostate Cancer, Prostate Cancer, Metastatic Brain Tumor, and Posterior Fossa Tumor.